Internal Medicine, Endocrinology, Diabetes, & Metabolism · Los Angeles, CA
NPI
1578719274
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1120 W Washington Blvd
Los Angeles, CA, 90015
Phone (213) 623-2225
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,995
92 services
Medicare patients, 2024
33
Average age 73
Drug cost, 2024
$2.6M
7,498 prescriptions
Company payments, 2023
$14.85
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shilpa Swamy was code 99214 (office e&m - established), 43 times for 26 patients. In total Shilpa Swamy billed 92 services in 10 codes, and Medicare paid $5,995.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 43 | 26 | $96.63 | $4,155 |
| 99211 Office E&M - Established | Office | 20 | 15 | $15.69 | $314 |
By year: 2022 $5,718 for 80 services; 2023 $5,812 for 74 services; 2024 $5,995 for 92 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shilpa Swamy prescribed most often to Medicare patients was Atorvastatin Calcium, with 857 prescriptions and refills. In total Shilpa Swamy wrote 7,498 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 857 | 2,487 | 317 | $9,605 |
| Ozempic Semaglutide | 675 | 821 | 118 | $741K |
| Jardiance Empagliflozin | 633 | 1,363 | 199 | $765K |
| Metformin Hcl Generic | 623 | 1,814 | 237 | $6,827 |
| Levothyroxine Sodium Generic | 428 | 1,269 | 156 | $6,662 |
| Pioglitazone Hcl Generic | 427 | 1,209 | 146 | $5,580 |
| Metformin Hcl Er Metformin Hcl | 419 | 1,203 | 157 | $6,644 |
| Trulicity Dulaglutide | 239 | 285 | 51 | $261K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 212 | 572 | 100 | $17K |
| Januvia Sitagliptin Phosphate | 141 | 351 | 47 | $183K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 141 | 368 | 56 | $23K |
| Glimepiride Generic | 139 | 395 | 43 | $1,236 |
| Humulin 70-30 Insulin Nph Hum/Reg Insulin Hm | 127 | 282 | 40 | $24K |
| Rosuvastatin Calcium Generic | 121 | 360 | 49 | $1,545 |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 114 | 301 | 44 | $34K |
Brand drugs: 3,109 claims; generic drugs: 3,656 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Shilpa Swamy $14.85 ($14.85 in general payments such as food, travel and fees) from 1 company. The largest payer was Insulet Corporation with $14.85.
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation PODD | 1 | $14.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.